Vutrisiran for treating transthyretin-related amyloidosis cardiomyopathy [ID6470]

  • In development
  • GID-TA11598
  • Expected publication date: 

28653-Vutrisiran-for-Transthyretin-Amyloid-Cardiomyopathy-V1.0-APR2024-NON-CONF.pdf (nihr.ac.uk)